Review



web-based software tool  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc web-based software tool
    Web Based Software Tool, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/prism+tool/pm36411514-82-1-4
    Average 90 stars, based on 1 article reviews
    web-based software tool - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Article Snippet: The high mortality rate due to chemoresistance in patients with high-grade ovarian cancer (HGSOC) emphasizes the urgent need to determine optimal treatment strategies for advanced and recurrent cases.. Our study investigates the interplay between estrogens and chemoresistance in HGSOC and shows clear differences between platinum-sensitive and -resistant tumors.. Through comprehensive transcriptome analyzes, we uncover differences in the expression of genes of estrogen biosynthesis, metabolism, transport and action underlying platinum resistance in different tissues of HGSOC subtypes and in six HGSOC cell lines.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd+ X) + NS*X + Background.

    Article Title: Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein
    Article Snippet: After subtracting out blank average values, standard curves were generated with the 5-PL curve fit analysis tool in Prism (GraphPad Software) and sample cytokine concentrations were quantified.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd +X) + NS*X + Background.

    Article Title: A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.
    Article Snippet: After adding the HRP-conjugated anti-Fab antibody, the signal was detected by measuring the absorbance at 450 nm, and the binding curves were obtained by using Prism (GraphPad Prism 5, version 10.0.0) tool.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS*X + Background.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS* X + Background.

    Binding Assay:

    Article Title: Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Article Snippet: The high mortality rate due to chemoresistance in patients with high-grade ovarian cancer (HGSOC) emphasizes the urgent need to determine optimal treatment strategies for advanced and recurrent cases.. Our study investigates the interplay between estrogens and chemoresistance in HGSOC and shows clear differences between platinum-sensitive and -resistant tumors.. Through comprehensive transcriptome analyzes, we uncover differences in the expression of genes of estrogen biosynthesis, metabolism, transport and action underlying platinum resistance in different tissues of HGSOC subtypes and in six HGSOC cell lines.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd+ X) + NS*X + Background.

    Article Title: Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein
    Article Snippet: After subtracting out blank average values, standard curves were generated with the 5-PL curve fit analysis tool in Prism (GraphPad Software) and sample cytokine concentrations were quantified.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd +X) + NS*X + Background.

    Article Title: A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.
    Article Snippet: After adding the HRP-conjugated anti-Fab antibody, the signal was detected by measuring the absorbance at 450 nm, and the binding curves were obtained by using Prism (GraphPad Prism 5, version 10.0.0) tool.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS*X + Background.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS* X + Background.

    Negative Control:

    Article Title: Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Article Snippet: The high mortality rate due to chemoresistance in patients with high-grade ovarian cancer (HGSOC) emphasizes the urgent need to determine optimal treatment strategies for advanced and recurrent cases.. Our study investigates the interplay between estrogens and chemoresistance in HGSOC and shows clear differences between platinum-sensitive and -resistant tumors.. Through comprehensive transcriptome analyzes, we uncover differences in the expression of genes of estrogen biosynthesis, metabolism, transport and action underlying platinum resistance in different tissues of HGSOC subtypes and in six HGSOC cell lines.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd+ X) + NS*X + Background.

    Article Title: Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein
    Article Snippet: After subtracting out blank average values, standard curves were generated with the 5-PL curve fit analysis tool in Prism (GraphPad Software) and sample cytokine concentrations were quantified.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd +X) + NS*X + Background.

    Article Title: A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.
    Article Snippet: After adding the HRP-conjugated anti-Fab antibody, the signal was detected by measuring the absorbance at 450 nm, and the binding curves were obtained by using Prism (GraphPad Prism 5, version 10.0.0) tool.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS*X + Background.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS* X + Background.

    Expressing:

    Article Title: Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Article Snippet: The high mortality rate due to chemoresistance in patients with high-grade ovarian cancer (HGSOC) emphasizes the urgent need to determine optimal treatment strategies for advanced and recurrent cases.. Our study investigates the interplay between estrogens and chemoresistance in HGSOC and shows clear differences between platinum-sensitive and -resistant tumors.. Through comprehensive transcriptome analyzes, we uncover differences in the expression of genes of estrogen biosynthesis, metabolism, transport and action underlying platinum resistance in different tissues of HGSOC subtypes and in six HGSOC cell lines.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd+ X) + NS*X + Background.

    Article Title: Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein
    Article Snippet: After subtracting out blank average values, standard curves were generated with the 5-PL curve fit analysis tool in Prism (GraphPad Software) and sample cytokine concentrations were quantified.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd +X) + NS*X + Background.

    Article Title: A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.
    Article Snippet: After adding the HRP-conjugated anti-Fab antibody, the signal was detected by measuring the absorbance at 450 nm, and the binding curves were obtained by using Prism (GraphPad Prism 5, version 10.0.0) tool.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS*X + Background.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS* X + Background.

    Comparison:

    Article Title: Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Article Snippet: The high mortality rate due to chemoresistance in patients with high-grade ovarian cancer (HGSOC) emphasizes the urgent need to determine optimal treatment strategies for advanced and recurrent cases.. Our study investigates the interplay between estrogens and chemoresistance in HGSOC and shows clear differences between platinum-sensitive and -resistant tumors.. Through comprehensive transcriptome analyzes, we uncover differences in the expression of genes of estrogen biosynthesis, metabolism, transport and action underlying platinum resistance in different tissues of HGSOC subtypes and in six HGSOC cell lines.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd+ X) + NS*X + Background.

    Article Title: Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein
    Article Snippet: After subtracting out blank average values, standard curves were generated with the 5-PL curve fit analysis tool in Prism (GraphPad Software) and sample cytokine concentrations were quantified.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd +X) + NS*X + Background.

    Article Title: A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.
    Article Snippet: After adding the HRP-conjugated anti-Fab antibody, the signal was detected by measuring the absorbance at 450 nm, and the binding curves were obtained by using Prism (GraphPad Prism 5, version 10.0.0) tool.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS*X + Background.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS* X + Background.

    MANN-WHITNEY:

    Article Title: Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance.
    Article Snippet: The high mortality rate due to chemoresistance in patients with high-grade ovarian cancer (HGSOC) emphasizes the urgent need to determine optimal treatment strategies for advanced and recurrent cases.. Our study investigates the interplay between estrogens and chemoresistance in HGSOC and shows clear differences between platinum-sensitive and -resistant tumors.. Through comprehensive transcriptome analyzes, we uncover differences in the expression of genes of estrogen biosynthesis, metabolism, transport and action underlying platinum resistance in different tissues of HGSOC subtypes and in six HGSOC cell lines.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd+ X) + NS*X + Background.

    Article Title: Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein
    Article Snippet: After subtracting out blank average values, standard curves were generated with the 5-PL curve fit analysis tool in Prism (GraphPad Software) and sample cytokine concentrations were quantified.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax*X/(Kd +X) + NS*X + Background.

    Article Title: A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.
    Article Snippet: After adding the HRP-conjugated anti-Fab antibody, the signal was detected by measuring the absorbance at 450 nm, and the binding curves were obtained by using Prism (GraphPad Prism 5, version 10.0.0) tool.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: The table reports the EC50 values obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS*X + Background.

    Article Title: Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
    Article Snippet: EC50 values are obtained by ELISA binding curve analyses with Prism (Graphpad) tool according to the following model: Y = Bmax* X /(Kd+ X ) + NS* X + Background.



    Similar Products

    86
    Biotechnology Information local alignment search tool primer blast web based software
    Local Alignment Search Tool Primer Blast Web Based Software, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/blast+primer/pmc12435708-57-17-13
    Average 86 stars, based on 1 article reviews
    local alignment search tool primer blast web based software - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc web-based software tool
    Web Based Software Tool, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/prism+tool/pm36411514-82-1-4
    Average 90 stars, based on 1 article reviews
    web-based software tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    QuestionPro Inc web-based software tool
    Web Based Software Tool, supplied by QuestionPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/web+based+software/pm36731919-83-14-18
    Average 90 stars, based on 1 article reviews
    web-based software tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Virtual Phantoms Inc the web-based virtualdose ct software tool
    The Web Based Virtualdose Ct Software Tool, supplied by Virtual Phantoms Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/the+web+based+virtualdose+ct+software+tool/pmc09783302-66-2-6
    Average 90 stars, based on 1 article reviews
    the web-based virtualdose ct software tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Qiagen web-based software rt2 profiler pcr array data analysis tool
    Web Based Software Rt2 Profiler Pcr Array Data Analysis Tool, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/rt2+profiler+pcr+array/10__1021_slash_acsfoodscitech__2c00205-53-8-15
    Average 90 stars, based on 1 article reviews
    web-based software rt2 profiler pcr array data analysis tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Qiagen ingenuity pathway analysis web-based bioinformatics application software tool
    Ingenuity Pathway Analysis Web Based Bioinformatics Application Software Tool, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/ingenuity+pathway+analysis+web+based+bioinformatics+application+software+tool/pm36078126-127-11-16
    Average 90 stars, based on 1 article reviews
    ingenuity pathway analysis web-based bioinformatics application software tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Synthego Inc free web-based software tool
    Free Web Based Software Tool, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/ice+software+tool/pm35203280-48-13-16
    Average 90 stars, based on 1 article reviews
    free web-based software tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    OpenClinica LLC web-based software tool
    Web Based Software Tool, supplied by OpenClinica LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+software+tool/web+based+software+tool/pm34993584-31-17-13
    Average 90 stars, based on 1 article reviews
    web-based software tool - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results